Moderna was a major player in the race to develop a vaccine for COVID-19. Now, according to a recent Engadget article, the company is using the same mRNA-based technology to combat the seasonal flu. The company announced last Wednesday that it has begun human trials as part of a Phase 1/2 clinical study.
Moderna’s mRNA Flu Vaccine Enters Trials
The same technology behind the COVID-19 vaccine looks to take on normal seasonal bugs next.
Jul 16, 2021
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now